These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 32742334

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Circular RNA cerebellar degeneration-related protein 1 antisense RNA (Circ-CDR1as) downregulation induced by dexmedetomidine treatment protects hippocampal neurons against hypoxia/reoxygenation injury through the microRNA-28-3p (miR-28-3p)/tumor necrosis factor receptor-associated factor-3 (TRAF3) axis.
    Wang J, Wang Y.
    Bioengineered; 2021 Dec; 12(2):10512-10524. PubMed ID: 34787053
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Dexmedetomidine protects cardiomyocytes against hypoxia/reoxygenation injury via multiple mechanisms.
    Cai S, Liu Y, Cheng Y, Yuan J, Fang J.
    J Clin Lab Anal; 2022 Jul; 36(7):e24119. PubMed ID: 34882841
    [Abstract] [Full Text] [Related]

  • 8. Dexmedetomidine abates myocardial ischemia reperfusion injury through inhibition of pyroptosis via regulation of miR-665/MEF2D/Nrf2 axis.
    Wang L, Liu J, Wang Z, Qian X, Zhao Y, Wang Q, Dai N, Xie Y, Zeng W, Yang W, Bai X, Yang Y, Qian J.
    Biomed Pharmacother; 2023 Sep; 165():115255. PubMed ID: 37549462
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dexmedetomidine alleviates myocardial ischemia/reperfusion-induced injury and Ca2+ overload via the microRNA-346-3p/CaMKIId axis.
    Zheng X, Li J, Fan Q, Zhao X, Chen K.
    Int J Cardiol; 2021 Sep 01; 338():185-195. PubMed ID: 33731281
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. MicroRNA-148b-3p is involved in regulating hypoxia/reoxygenation-induced injury of cardiomyocytes in vitro through modulating SIRT7/p53 signaling.
    Sun M, Zhai M, Zhang N, Wang R, Liang H, Han Q, Jia Y, Jiao L.
    Chem Biol Interact; 2018 Dec 25; 296():211-219. PubMed ID: 30308185
    [Abstract] [Full Text] [Related]

  • 16. The inhibition of miR‑101a‑3p alleviates H/R injury in H9C2 cells by regulating the JAK2/STAT3 pathway.
    Liu J, Wang J, Ning Y, Chen F.
    Mol Med Rep; 2020 Jan 25; 21(1):89-96. PubMed ID: 31746349
    [Abstract] [Full Text] [Related]

  • 17. MiR-181c-5p Promotes Inflammatory Response during Hypoxia/Reoxygenation Injury by Downregulating Protein Tyrosine Phosphatase Nonreceptor Type 4 in H9C2 Cardiomyocytes.
    Wang S, Ge L, Zhang D, Wang L, Liu H, Ye X, Liang W, Li J, Ma H, Cai Y, Xia Z.
    Oxid Med Cell Longev; 2020 Jan 25; 2020():7913418. PubMed ID: 32774684
    [Abstract] [Full Text] [Related]

  • 18. Dexmedetomidine inhibits pyroptosis by down-regulating miR-29b in myocardial ischemia reperfusion injury in rats.
    Zhong Y, Li YP, Yin YQ, Hu BL, Gao H.
    Int Immunopharmacol; 2020 Sep 25; 86():106768. PubMed ID: 32679539
    [Abstract] [Full Text] [Related]

  • 19. Hypoxia-elicited cardiac microvascular endothelial cell-derived exosomal miR-210-3p alleviate hypoxia/reoxygenation-induced myocardial cell injury through inhibiting transferrin receptor 1-mediated ferroptosis.
    Lei D, Li B, Isa Z, Ma X, Zhang B.
    Tissue Cell; 2022 Dec 25; 79():101956. PubMed ID: 36272206
    [Abstract] [Full Text] [Related]

  • 20. Dexmedetomidine suppresses hippocampal astrocyte pyroptosis in cerebral hypoxic-ischemic neonatal rats by upregulating microRNA-148a-3p to inactivate the STAT/JMJD3 axis.
    Zhong Y, Wang S, Yin Y, Yu J, Liu Y, Gao H.
    Int Immunopharmacol; 2023 Aug 25; 121():110440. PubMed ID: 37327511
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.